[go: up one dir, main page]

EE05394B1 - Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis - Google Patents

Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis

Info

Publication number
EE05394B1
EE05394B1 EEP200500033A EEP200500033A EE05394B1 EE 05394 B1 EE05394 B1 EE 05394B1 EE P200500033 A EEP200500033 A EE P200500033A EE P200500033 A EEP200500033 A EE P200500033A EE 05394 B1 EE05394 B1 EE 05394B1
Authority
EE
Estonia
Prior art keywords
treatment
quinoline compounds
latent tuberculosis
tuberculosis
latent
Prior art date
Application number
EEP200500033A
Other languages
English (en)
Inventor
Jozef Lodewijk Marcel Andries Koenraad
Koul Anil
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35717702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05394(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200500033A publication Critical patent/EE200500033A/et
Publication of EE05394B1 publication Critical patent/EE05394B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200500033A 2004-12-24 2005-12-05 Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis EE05394B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04078529 2004-12-24
EP05105008 2005-06-08

Publications (2)

Publication Number Publication Date
EE200500033A EE200500033A (et) 2006-08-15
EE05394B1 true EE05394B1 (et) 2011-04-15

Family

ID=35717702

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200500033A EE05394B1 (et) 2004-12-24 2005-12-05 Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis

Country Status (30)

Country Link
US (1) US20060142279A1 (et)
EP (1) EP1830850B1 (et)
CN (1) CN103142595B (et)
AP (1) AP2327A (et)
AR (1) AR051790A1 (et)
AT (1) ATE501721T1 (et)
AU (1) AU2005242138B2 (et)
BR (1) BRPI0506400B8 (et)
CA (1) CA2529265C (et)
CR (1) CR9267A (et)
CY (1) CY1112247T1 (et)
DE (1) DE602005026984D1 (et)
DK (1) DK1830850T3 (et)
EE (1) EE05394B1 (et)
HR (1) HRP20110392T1 (et)
IL (1) IL184123A (et)
LV (1) LV13469B (et)
ME (1) ME01207B (et)
MY (1) MY145845A (et)
NI (1) NI200700146A (et)
NO (1) NO340376B1 (et)
NZ (1) NZ555460A (et)
PA (1) PA8654801A1 (et)
PL (1) PL1830850T3 (et)
PT (1) PT1830850E (et)
RS (1) RS51730B (et)
SI (1) SI1830850T1 (et)
TR (1) TR200504892A1 (et)
TW (1) TWI404535B (et)
WO (1) WO2006067048A1 (et)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2301544T3 (da) * 2002-07-25 2013-01-02 Janssen Pharmaceutica Nv Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer
JO2752B1 (en) * 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
DK1898909T3 (en) * 2005-06-28 2017-02-06 Janssen Pharmaceutica Nv QUINOLIN DERIVATIVES AS ANTIBACTERIAL AGENTS
JO3270B1 (ar) * 2005-06-28 2018-09-16 Janssen Pharmaceutica Nv مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO2725B1 (en) * 2006-12-06 2013-09-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO3271B1 (ar) * 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
US20110059948A1 (en) * 2008-01-14 2011-03-10 Jyoti Chattopadhyaya Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents
RU2404971C2 (ru) * 2008-12-02 2010-11-27 ЗАО "Фарм-Синтез" Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе
CA2751892A1 (en) 2009-01-15 2010-07-22 Rutgers, The State University Of New Jersey Benzo [c] phenanthridines as antimicrobial agents
US20120059026A1 (en) 2009-04-30 2012-03-08 University Of Medicine And Dentistry Of New Jersey Antimicrobial agents
CA2810162A1 (en) 2010-06-09 2011-12-15 Rutgers, The State University Of New Jersey Antimicrobial agents
US9102617B2 (en) 2010-06-25 2015-08-11 Rutgers, The State University Of New Jersey Antimicrobial agents
US9822108B2 (en) 2012-01-13 2017-11-21 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013142712A1 (en) 2012-03-21 2013-09-26 Rutgers, The State University Of New Jersey Antimicrobial agents
AU2013254670B2 (en) 2012-04-27 2017-03-30 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
CN104254527B (zh) 2012-04-27 2017-05-31 詹森药业有限公司 抗菌的喹啉衍生物
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
FI3250182T3 (fi) 2015-01-27 2023-06-28 Janssen Pharmaceutica Nv Dispergoituvia koostumuksia
EP3419967A4 (en) 2016-02-25 2019-10-16 Taxis Pharmaceuticals, Inc. METHODS AND INTERMEDIARIES FOR SYNTHESIS
CA3016068C (en) * 2016-03-07 2024-02-27 The Global Alliance For Tb Drug Development, Inc. Antibacterial compounds and uses thereof
RU2629369C1 (ru) * 2016-10-05 2017-08-29 Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ" Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью
CA3058183A1 (en) 2017-03-30 2018-10-04 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates
SI3943070T1 (sl) 2017-07-14 2024-03-29 Janssen Pharmaceutica Nv, Dolgo delujoče formulacije bedakilina
RU2661151C1 (ru) * 2017-12-14 2018-07-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий
WO2020144197A1 (en) 2019-01-09 2020-07-16 Janssen Pharmaceutica Nv Combination in the treatment of nontuberculous mycobacterial diseases
MX2023000439A (es) 2020-07-09 2023-02-09 Janssen Pharmaceutica Nv Formulaciones a largo plazo.
CA3182854A1 (en) 2020-07-09 2022-01-13 Rene Holm Long-acting formulations
KR20230107275A (ko) 2020-11-12 2023-07-14 얀센 파마슈티카 엔.브이. 비결핵성 마이코박테리아 질환의 치료에서 베다퀼린, 에탐부톨 및 마크롤라이드의 조합물
WO2023232838A1 (en) 2022-05-31 2023-12-07 Janssen Pharmaceutica Nv Bedaquiline for use in the treatment of leprosy
WO2024068699A1 (en) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Long-acting formulations
WO2024068693A1 (en) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Long-acting formulations
WO2025068448A1 (en) 2023-09-28 2025-04-03 Janssen Pharmaceutica Nv Atp synthase inhibitors for use in the treatment of non-tuberculosis mycobacteria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
DK2301544T3 (da) * 2002-07-25 2013-01-02 Janssen Pharmaceutica Nv Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer

Also Published As

Publication number Publication date
BRPI0506400B1 (pt) 2021-04-06
CA2529265C (en) 2014-02-11
CA2529265A1 (en) 2006-06-24
TR200504892A1 (tr) 2010-04-21
AU2005242138A1 (en) 2006-07-13
AP2007004054A0 (en) 2007-06-30
BRPI0506400B8 (pt) 2021-05-25
NO20073823L (no) 2007-07-23
AU2005242138B2 (en) 2011-05-26
NO340376B1 (no) 2017-04-10
HK1186125A1 (en) 2014-03-07
ME01207B (me) 2013-03-20
US20060142279A1 (en) 2006-06-29
HRP20110392T1 (hr) 2011-06-30
AP2327A (en) 2011-11-25
BRPI0506400A (pt) 2006-08-29
CN103142595B (zh) 2015-05-06
PA8654801A1 (es) 2006-08-03
PL1830850T3 (pl) 2011-07-29
WO2006067048A1 (en) 2006-06-29
EE200500033A (et) 2006-08-15
DK1830850T3 (da) 2011-06-14
AR051790A1 (es) 2007-02-07
DE602005026984D1 (de) 2011-04-28
RS51730B (sr) 2011-10-31
LV13469B (en) 2007-01-20
CN103142595A (zh) 2013-06-12
MY145845A (en) 2012-04-30
TWI404535B (zh) 2013-08-11
NZ555460A (en) 2008-11-28
IL184123A0 (en) 2008-12-29
EP1830850B1 (en) 2011-03-16
NI200700146A (es) 2019-05-10
PT1830850E (pt) 2011-05-31
BRPI0506400A8 (pt) 2017-09-12
EP1830850A1 (en) 2007-09-12
TW200637551A (en) 2006-11-01
SI1830850T1 (sl) 2011-07-29
IL184123A (en) 2011-10-31
CY1112247T1 (el) 2015-12-09
CR9267A (es) 2008-09-09
ATE501721T1 (de) 2011-04-15

Similar Documents

Publication Publication Date Title
EE05394B1 (et) Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
CY2017013I2 (el) ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ
IL181524A0 (en) Heterocyclic compounds and methods of use
DK1720554T3 (da) Anvendelse af meloxicam til behandling af luftvejssygdomme hos svin
DE602005005810D1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
IL180929A0 (en) The use of n-aryl diazaspiracyclic compounds in the treatment of addiction
DE602005018315D1 (de) Rollstuhl
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
HRP20150320T1 (xx) Formulacije i metode za lijeäśenje amiloidoze
EP2111484A4 (en) POLYAMINE BRILLIANCE AGENT
PL1763520T3 (pl) Zastosowanie tripodstawionych benzopiranonów
ZA200705160B (en) Quinoline derivatives for the treatment of latent tuberculosis
FI20040180L (fi) Koostumus psoriasis-taudin hoitamiseksi
DK2301576T3 (da) Terapeutisk anvendelse af anti-CS1-antistoffer
SE0400718D0 (sv) Therapeutic agents
SE0403119D0 (sv) Therapeutic agents
SE0400613D0 (sv) New compounds and use thereof
SE0402780D0 (sv) Therapeutic agents
HUE036189T2 (hu) Monofenol, benzoldiol vagy szulfhidril vegyületek melanómák kezelésében való alkalmazásra
EE200400064A (et) Ambroksooli kasutamine neelupõletiku ravimiseks
SE0401715D0 (sv) New use
SE0402392D0 (sv) New use

Legal Events

Date Code Title Description
HC1A Change of owner name